The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Dec / Full Power for 2021
Business & Regulation Business & Trends Sponsored

Full Power for 2021

Nominations for The Medicine Maker Power List will close on January 25

By Stephanie Vine 12/17/2020 1 min read Quick Read (pre 2022)

Share

The Medicine Maker 2021 Power List will be published in April to celebrate the great minds and personalities that contribute to the development of new medicines – including small molecules, biopharmaceuticals, and advanced medicines. Nominations can be submitted using the quick form at http://tmm.txp.to/pl2021-noms.

Who is eligible? You can nominate anyone involved in the development or manufacture of new medicinal products – and we invite nominations from all corners of the industry including big pharma, startups, research institutes, societies, regulators, NPOs, academia and more. 

We want to celebrate the diverse talent and experience that makes the pharma industry tick – please join us! 

For inspiration or reference, the 2020 Power List can found at: www.themedicinemaker.com/power-list/2020

Questions? Email stephanie.sutton@texerepublishing.com

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

Recommended

Related Content

What Trump’s Latest Moves Mean for the Industry
Interviews Bioprocessing Business & Trends
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

FDA to Phase Out Animal Testing
Regulation & Standards Business & Trends Development & Clinical
FDA to Phase Out Animal Testing

April 11, 2025

2 min read

FDA to phase out mandatory animal testing with human-relevant methods for drug development

Partnerships To Be Precise
Outsourcing Business & Trends
Partnerships To Be Precise

April 11, 2025

3 min read

In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Trump Speech Suggests Pharma Tariffs Incoming
Regulation & Standards Business & Trends Supply Chain
Trump Speech Suggests Pharma Tariffs Incoming

April 9, 2025

2 min read

US President threatens “major tariff” on pharmaceuticals.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: